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doctors enabling a more precise diagnosis and more
accurate titration of treatment in the long term follow
up of hypertension.
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Primary care trusts
Premature reorganisation, with mergers, may be harmful
Just over two years ago, in a reorganisation of theNHS in England, 303 primary care trusts were cre-ated, each with responsibility for providing primary
health care, improving health, and commissioning
secondary care services for a population of around
180 000. With about 80% of NHS funding flowing
directly to primary care trusts on a capitation based
formula, hopes were high that these new organisations
would be powerful agents for change in a more
devolved, clinically driven, and locally responsive
NHS.1
Some in the NHS, however, believe that primary
care trusts have failed to fulfil these expectations. There
is a growing belief that many trusts are perhaps
ineffective organisations—too weak to stand up to pro-
viders of acute care in tough negotiations on commis-
sioning and too small to fulfil their public health
responsibilities. Some would argue that they have so
far been unable to establish strong and credible
management teams.2
The unsurprising solution being mooted is a
further reorganisation, in which widespread mergers
of primary care trusts would reduce their number to
100-150 across England.3 Coincidentally, that is
roughly how many health authorities existed before
they were abolished and primary care trusts were
created to take on many of their responsibilities.
Although a moratorium of sorts on wholesale
organisational restructuring has been in place for the
past two years in the Department of Health, some
primary care trusts have already been merged in all
but name. Strategic health authorities have
organised them into “clusters” and appointed joint
management teams.4 In 2005—after the next election—
we expect an epidemic of mergers of primary care
trusts.
So what would these mergers achieve? We have no
good evidence to show that a structural reorganisation
of primary care trusts would bring benefit to patients.
It would lead to a distraction from the real tasks at
hand such as developing clinical governance and new
forms of management for chronic disease; implement-
ing new incentive structures, such as practice based
commissioning, to improve coordination of services
and deal with poor morale; and using new policies
such as payment by results and choice for patients as a
lever for developing services that are more responsive
to local people.5 Primary care trusts have so far
made some progress, but they have important
problems to tackle.6 7 The growing and somewhat
self fulfilling beliefs that they are not fit for their
purpose in the longer term and that structural
reorganisation would bring improvement deserve to
be challenged.
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Firstly, primary care organisations do not have one
right size and configuration. The advantages of being
big for managing risk and exploiting economies of
scale in management clash with the advantages of
being small, close to primary care, and adaptable to
local needs.8 However, many primary care trusts
already struggle to secure clinical engagement and
support among general practitioners because of their
size and the number of practices they cover. Larger
primary care trusts would seem more remote and
bureaucratic to clinicians. Securing clinical involve-
ment and leadership are crucial to the success of
primary care organisations as providers and commis-
sioners and to developing practice based commission-
ing.9 10
Secondly, although primary care trusts have not yet
had time to become effective negotiators in their com-
missioning relations with acute care providers or to
develop their planning and purchasing capacity, we
have no evidence to show that the old health authori-
ties that were larger than current primary care trusts
were any better at commissioning.11 We know that flex-
ible arrangements are needed to let commissioning
take place at different population levels, depending on
the nature of the service.12
Thirdly, although management teams of primary
care trusts are still immature and inexperienced, this
will resolve over time. The rush to reorganise and
merge fails to recognise that many primary care trusts
are already developing creative and flexible arrange-
ments for the sharing of expertise and functions with
neighbouring trusts.13 Countywide or citywide net-
works for public health, commissioning arrangements,
shared senior executive posts, and agencies to provide
support services are examples of such innovation.
These are happening in response to local need—not
prescribed from above by strategic health authorities
or the Department of Health.
Reorganisations are a clumsy reform tool, and
research shows that they seldom deliver the promised
benefits. Every reorganisation produces a transient
drop in performance,14 and it takes a new organisation
at least two to three years to become established and
start to perform as well as its predecessor. Yet the NHS
is reorganised every two years or so, which probably
means it sees all the costs of each reorganisation and
few of the benefits. In a truly devolved NHS that is
clinically driven and locally responsive, top down
reorganisations should become outdated. To propose
making major structural changes to primary care
trusts is premature. What they need instead is
the space to work on implementing current policy ini-
tiatives and seeing their effects, building relations in
local healthcare communities, and securing much
needed clinical engagement and improvement in
service. The Department of Health and NHS manag-
ers should resist the temptation to reach for the old
panacea of reorganisation.
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